Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion type Assertion NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_head.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion description "[The results of the present study suggest the clinical use of trastuzumab for HER-2-overexpressing esophageal cancer, which is a significant fraction of the patient population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_provenance.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion evidence source_evidence_literature NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_provenance.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion SIO_000772 20606043 NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_provenance.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion wasDerivedFrom befree-20150227 NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_provenance.
- NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_assertion wasGeneratedBy ECO_0000203 NP378915.RAVbukTKgIuLZmEhi9XI8kZVsNSdk9ldlKH5J8NaJswlc130_provenance.